Clinical significance of homologous recombination deficiency (HRD) score testing in endometrial cancer patients.

被引：2
|
作者：
Hansen, Jean M.
Ring, Karl Lassen
Baggerly, Keith A.
Wu, Sherry
Timms, Kirsten
Neff, Christopher
Hughes, Elisha
Previs, Rebecca A.
Broaddus, Russell
Coleman, Robert L.
Lu, Karen H.
Sood, Anil
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[2] Myriad Genetics Inc, Salt Lake City, UT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.5584
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5584
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Homologous recombination deficiency and platinum rechallenge in platinum-resistant ovarian cancer patients.
    Da Costa, Alexandre Andre B. A.
    Salvadori, Marcela Marinelli
    Valadares, Camila Vieira
    Stecca, Carlos
    Brot, Louise
    do Canto, Luisa Matos
    Baiocchi, Glauco
    Rogatto, Silvia Regina
    Achatz, Maria Isabel Waddington
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [42] Characterization of mutational signatures of homologous recombination deficiency (HRD) in Chinese breast cancer.
    Liu, Xiao
    Li, Mingwei
    Lou, Feng
    Cao, Shanbo
    Wang, Huina
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [43] The correlation of homologous recombination deficiency status with and Olaparib efficacy in Chinese ovarian cancer patients.
    Peng, Yongpai
    Xie, Qingsheng
    Xu, Guocai
    Zhang, Bingzhong
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E17556 - E17556
  • [44] Homologous recombination deficiency (HRD) testing on cell-free tumor DNA in ascites of patients with newly diagnosed advanced epithelial ovarian cancer
    Roussel-Simonin, Cyril
    Blanc-Durand, Felix
    Roueau, Etienne
    Le Formal, Audrey
    Chardin, Laure
    Yaniz, Elisa
    Gouy, Sebastien
    Maulard, Amandine
    Cherrier, Stephanie
    Sanson, Claire
    Mauny, Lea
    Coterret, Sophie
    Zaccarini, Francois
    Tang, Roseline
    Leary, Alexandra
    CANCER RESEARCH, 2023, 83 (07)
  • [45] Anthracycline-related cardiotoxicity in breast cancer patients carrying mutational signature of homologous recombination deficiency (HRD)
    Incorvaia, L.
    Fiorino, A.
    Gori, S.
    Cinieri, S.
    Curigliano, G.
    Toss, A.
    Cortesi, L.
    Ricciardi, G. R. R.
    Chiari, R.
    Peri, M.
    Brando, C.
    Russo, T. D. Bazan
    Gristina, V.
    Galvano, A.
    Damerino, G.
    Carreca, I. U.
    Novo, G.
    Badalamenti, G.
    Bazan, V.
    Russo, A.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S961 - S962
  • [46] Pregnancy and miscarriage in epithelial ovarian cancer (EOC) patients harboring mutational signature of homologous recombination deficiency (HRD)
    Incorvaia, L.
    Russo, T. D. Bazan
    Perez, A.
    Brando, C.
    Ferraro, P.
    Simone, A.
    Bono, M.
    Castellana, L.
    Insalaco, L.
    Contino, S.
    Gottardo, A.
    Gristina, V.
    Galvano, A.
    Corsini, L. R.
    Fanale, D.
    Badalamenti, G.
    Russo, A.
    Bazan, V.
    ANNALS OF ONCOLOGY, 2024, 35 : S955 - S955
  • [47] Anthracycline-related cardiotoxicity in patients with breast cancer harboring mutational signature of homologous recombination deficiency (HRD)
    Incorvaia, L.
    Badalamenti, G.
    Novo, G.
    Gori, S.
    Cortesi, L.
    Brando, C.
    Cinieri, S.
    Curigliano, G.
    Ricciardi, G. R.
    Toss, A.
    Chiari, R.
    Berardi, R.
    Ballatore, Z.
    Bono, M.
    Russo, T. D. Bazan
    Gristina, V.
    Galvano, A.
    Damerino, G.
    Blasti, L.
    Bazan, V.
    Russo, A.
    ESMO OPEN, 2024, 9 (01)
  • [48] Homologous Recombination Deficiency in Breast Cancer: A Clinical Review
    den Brok, Wendie D.
    Schrader, Kasmintan A.
    Sun, Sophie
    Tinker, Anna V.
    Zhao, Eric Yang
    Aparicio, Samuel
    Gelmon, Karen A.
    JCO PRECISION ONCOLOGY, 2017, 1 : 1 - 13
  • [49] Optimized molecular classification of endometrial carcinoma-based on the combination of POLE mutations with homologous recombination deficiency (HRD).
    Gao, Min
    Wang, Wei
    Li, Qian
    Zheng, Hong
    Gao, Weijiao
    Zhang, Naiyi
    Shu, Tong
    Zhang, Nan
    Wang, Hongguo
    Gao, Yunong
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E17628 - E17628
  • [50] Homologous recombination deficiency (HRD) in primary advanced stage and recurrent P53 abnormal endometrial carcinoma
    Mittelstadt, Suzana
    Staebler, Annette
    Walter, Christina
    Denkert, Carsten
    Knoll, Katharina
    Zeimet, Alain
    Kommoss, Stefan
    Grube, Marcel Philip
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A208 - A209
12345